ADVERTISEMENT

Medical News

EMA calls for removal of obesity drug from European Union

Dawn O'Shea   |   31 October 2022

The safety committee (PRAC) of the European Medicines Agency (EMA) has recommended that amfepramone-containing obesity medicines be removed from the European market, despite pleas from drug companies.

The EMA initially made its recommendation to withdraw marketing authorisation for these medicines in June 2022, following a safety review which found that...

          

November Challenge

Ends in 1d 6h
left
right

Topic Challenges

left
right